Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DHCR24-DT (DHCR24 divergent transcript) is a non-coding RNA gene located in proximity to the DHCR24 protein-coding gene, which encodes 24-dehydrocholesterol reductase—a key enzyme in cholesterol biosynthesis. The divergent transcript is not a protein, therapeutic target, or classified receptor/enzyme, but may have regulatory genomic functions yet to be clarified. No information is available supporting its use, interaction with drugs, disease association, or role as a biomarker. The terms “ESSENCE, EGF Signal Sensing CAD’s Effect” are not referenced in standard gene, protein, or drug databases and appear to be incorrect or speculative aliases for DHCR24-DT. There is no evidence that DHCR24-DT functions in EGF signaling, CAD effect, or cholesterol biosynthesis as a protein or molecular target. If you are seeking information regarding the protein DHCR24 (24-dehydrocholesterol reductase), it is a well-established enzyme in cholesterol metabolism and associated with diseases such as desmosterolosis. However, DHCR24-DT (the divergent transcript) remains a poorly characterized non-coding RNA.
None established for drugs, as DHCR24-DT is not an established drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DHCR24 divergent transcript (DHCR24-DT).